Bio Protocol vs Covalent X Token — how do they compare? Bio Protocol trades at Rp494.21 (market cap Rp1,11T, Rp291,14M 24h volume), while Covalent X Token trades at Rp68.04 (market cap Rp65,77M, Rp3,86M 24h volume). The key difference: Bio Protocol is far larger — about 16877× Covalent X Token's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 967,1M / 1B CXT (97%) for Covalent X Token. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Covalent X Token for 9 Days on average.
| BIO | CXT | |
|---|---|---|
Market Cap | Rp1,11T | Rp65,77M |
Volume (24h) | Rp291,14M | Rp3,86M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 967,1M / 1B CXT (97%) |
Typical Hold Time | 16 Days | 9 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Covalent X Token (CXT) is currently trading at Rp70.5502 with a market cap of Rp67.43M. Technical indicators show a strong bearish trend with moving averages unanimously negative, though oscillators are neutral. RSI levels at 15.30 (6-day) and 14.40 (12-day) suggest oversold conditions. The token faces immediate support at Rp70 and resistance at Rp72. No major protocol updates or ecosystem developments were identified in recent crypto-specific sources.
Overall outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential rebound from oversold RSI levels, but risks include high volatility, limited exchange presence, and regulatory uncertainty. Investors should monitor for any network updates or increased adoption to shift momentum.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →CXT is the utility and governance token of the Covalent Network, which safeguards Ethereum’s historical data. It is used for staking and enables holders to participate in decentralized governance. The network enhances data availability for developers building on the Ethereum ecosystem.
Read more on CXT →